You are here

Article info

Article menu

Download PDFPDF

Oncology
Original research
Cancer prevalence after exposure to Wnt-activating drugs: a systematic review

Authors

  • Ahmed Alkashaf Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Natalia Smith-Cortinez Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The NetherlandsUMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Georgina E Fenton Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The NetherlandsUMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Sebastian Thomas Bok Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Robert J Stokroos Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The NetherlandsUMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Inge Stegeman Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The NetherlandsUMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Louise V Straatman Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The NetherlandsUMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Natalia Smith-Cortinez; n.f.smithcortinez{at}umcutrecht.nl
View Full Text

Citation

Alkashaf A, Smith-Cortinez N, Fenton GE, et al
Cancer prevalence after exposure to Wnt-activating drugs: a systematic review
BMJ Open 2025;15:e103296. doi: 10.1136/bmjopen-2025-103296

Publication history

  • Received April 7, 2025
  • Accepted May 7, 2025
  • First published May 30, 2025.
Online issue publication 
May 30, 2025
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.